Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

被引：0

作者：

Baldini, C. ^{[1
]}

Danlos, F-X. ^{[2
]}

Varga, A. ^{[1
]}

Halse, H. ^{[3
]}

Mouraud, S. ^{[4
]}

Cassard, L. ^{[5
,6
]}

Bredel, D. ^{[4
]}

Escriou, G. ^{[4
]}

Parpaleix, A. ^{[7
]}

Rafie, S. ^{[1
]}

Abbassi, A. E. ^{[1
]}

Laghouati, S. ^{[8
]}

Farhane, S. ^{[1
]}

Tselikas, L. ^{[9
]}

Texier, M. ^{[10
]}

Adam, J. ^{[11
]}

Chaput, N. ^{[12
]}

Soria, J-C. ^{[13
]}

Massard, C. ^{[1
]}

Marabelle, A. ^{[14
]}

机构：

[1] Gustave Roussy, Drug Dev Dept, Villejuif, France

[2] Gustave Roussy, Drug Dev Dept, INSERM UMR1015, Villejuif, France

[3] Gustave Roussy, INSERM U1163, Imagine Inst, Villejuif, France

[4] Gustave Roussy, INSERM UMR1015, Villejuif, France

[5] Univ Paris Saclay, Gustave Roussy, Lab Immunomonitoring Oncol, CNRS UMS 3655, Villejuif, France

[6] Paris Saclay Univ, Gustave Roussy, INSERM US23, Villejuif, France

[7] Gustave Roussy, Serv Promot Etud Clin, Direct Rech Clin, Villejuif, France

[8] Gustave Roussy, Pharmacovigilance Dept, Villejuif, France

[9] Gustave Roussy Canc Campus, Intervent Radiol, Villejuif, France

[10] Gustave Roussy, Biostat, Villejuif, France

[11] Grp Hosp Paris St Joseph, Dept Pathol, Paris, France

[12] Univ Paris Saclay, UMR9019, Lab Immunomonitoring Oncol,CNRS, Gustave Roussy,Equipe Labellisee Ligue Natl Canc, Villejuif, France

[13] Inst Gustave Roussy, Direct Gen, Villejuif, France

[14] Inst Gustave Roussy, Drug Dev Dept, INSERM, UMR1015, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.1368

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

984P

引用

页码：S842 / S843

页数：2

共 50 条

[1] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial).
Varga, Andreea
Baldini, Capucine
Martin-Romano, Patricia
Besse, Benjamin
Planchard, David
Champiat, Stephane
Angevin, Eroc
Hollebecque, Antoine
Bahleda, Rastislav
Gazzah, Anas
Armand, Jean-Pierre
Paoletti, Xavier
Massard, Christophe
Soria, Jean-Charles
Marabelle, Aurelien
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
Varga, Andreea
Baldini, Capucine
Martin-Romano, Patricia
Hollebecque, Antoine
Gazzah, Anas
Bahleda, Rastislav
Menis, Jessica
Champiat, Stephane
El-Dakdouki, Yolla
Paoletti, Xavier
Ribrag, Vincent
Michot, Jean-Marie
Rafie, Saloomeh
Planchard, David
Besse, Benjamin
Massard, Christophe
Soria, Jean-Charles
Marabelle, Aurelien
[J]. CANCER RESEARCH, 2018, 78 (13)
[3] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
Rasco, Drew W.
Eckhardt, S. Gail
Davar, Diwakar
Lewis, Karl
Lara-Guerra, Humberto
Alters, Susan E.
Eckert, Stephen
Rowlinson, Scott W.
Wooldridge, James E.
Carvajal, Richard D.
[J]. CANCER RESEARCH, 2018, 78 (13)
[4] Phase I dose escalation trial of biweekly pemetrexed in combination with docetaxel in advanced solid tumors
Garland, L. L.
Cranmer, L., III
Gerstner, G.
Walker, R.
Obregon, Y.
Ebbinghaus, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[5] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
Wang-Gillam, A.
Yeckes-Rodin, H.
Kosmo, M. A.
Stanton, T.
Park, H.
Songhua, F.
Sauter, N. P.
Kania, M.
[J]. ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
[6] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
Véronique Diéras
Thomas Bachelot
Mario Campone
Nicolas Isambert
Florence Joly
Christophe Le Tourneau
Philippe Cassier
Emmanuelle Bompas
Pierre Fumoleau
Sabine Noal
Christine Orsini
Marta Jimenez
Diane Charlotte Imbs
Etienne Chatelut
[J]. Oncology and Therapy, 2016, 4 (2) : 211 - 223
[7] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Tourneau, Christophe
Cassier, Philippe
Bompas, Emmanuelle
Fumoleau, Pierre
Noal, Sabine
Orsini, Christine
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
[J]. ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
[8] A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors
Gordon, Michael S.
Springett, Gregory M.
Su, Yungpo Bernard
Ould-Kaci, Mahmoud
Wind, Sven
Zhao, Yihua
LoRusso, Patricia M.
[J]. FUTURE ONCOLOGY, 2015, 11 (10) : 1479 - 1491
[9] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
Ravi Paluri
Ankit Madan
Peng Li
Benjamin Jones
Mansoor Saleh
Mary Jerome
Deborah Miley
Jennifer Keef
Francisco Robert
[J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 551 - 559
[10] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
Paluri, Ravi
Madan, Ankit
Li, Peng
Jones, Benjamin
Saleh, Mansoor
Jerome, Mary
Miley, Deborah
Keef, Jennifer
Robert, Francisco
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 551 - 559

← 1 2 3 4 5 →